Skip to content
    MPT
    Earnings call· Jun 2026(Q2 FY26)

    MEDICAL PROPERTIES TRUST Q2 FY26 earnings call MPT

    Aug 10, 2026 Source

    Executive summary

    Medical Properties Trust Q2 FY26 — Debt Refinancing and Asset Sales Strengthen Balance Sheet

    Medical Properties Trust executed a significant debt refinancing in Q2 FY26, pushing out substantial maturities and improving its liquidity profile. The company continues to see strong performance in its post-acute portfolio, while addressing challenges in behavioral health and specific U.S. operators. Strategic asset sales are validating portfolio values and providing capital for deleveraging, positioning MPT for a more balanced capital allocation strategy.

    Highlights

    5

    • Comprehensive refinancing transaction extends $2.4 billion of debt maturities to 2032, significantly reducing near-term maturities.

    • Post-acute operators delivered strong growth with EBITDARM increasing over $70 million year-over-year, including a 24% increase at Median and 13% at Ernest Health.

    • Recent asset sales and the Infracore IPO validated asset values, with one pending sale reflecting a 60% increase over original investment and a 34% IRR.

    • Consolidated ScionHealth and LifePoint leases into a single LifePoint master lease, enhancing credit profile.

    • UA UD bond covenant cushion expected to improve from 155-160% to almost 200% after Step 1, and up to 300% after Step 2.

    Concerns

    4

    • Behavioral Health remains a source of pressure, with U.K. market revenue impacted by NHS funding constraints, leading to 1.4x EBITDARM coverage.

    • HSA experienced mixed results due to MEDITECH EMR conversion issues and delayed Florida supplemental funding, causing lower cash collections and volume declines.

    • G&A expense was higher year-over-year primarily due to stock compensation and depreciation from the corporate headquarters building.

    • Impaired approximately $17 million in working capital loans primarily related to Steward replacement tenants in the Midwest.

    Guidance & targets

    1
    CategoryTargetConfidence
    Annualized cash rent
    Over $1 billion
    high materiality
    High

    Segment performance

    3
    SegmentRevenueYoYQoQMargin
    General Acute
    Comprises the majority of the portfolio; performance trends remain broadly stable.
    EBITDARM coverage: 2.8x
    		————
    Post-Acute
    Delivered strong performance, with EBITDARM increasing over $70 million year-over-year.
    EBITDARM coverage: 2.4x
    		————
    Behavioral Health
    Coverage was down slightly due to discrete headwinds in the U.K. and U.S. markets.
    EBITDARM coverage: 1.4x
    		————

    Operational metrics

    31
    Normalized FFO per share
    $0.15up from $0.14
    Q2 FY26

    In line with expectations.

    Normalized FFO per share
    $0.14
    Q1 FY26

    Prior quarter's result.

    G&A expense
    higher
    YoY

    Primarily driven by stock compensation expense and increased depreciation at corporate headquarters.

    Working capital loans impaired
    $17 million
    Q2 FY26

    Primarily related to 2 Steward replacement tenants in the Midwest.

    Debt maturities extended
    $2.4 billion
    to 2032

    Comprehensive refinancing transaction.

    Unsecured notes due 2026 redeemed
    EUR 500 million
    Q2 FY26

    Part of Step 1 of the refinancing.

    Unsecured notes due 2027 redeemed
    $738 million
    Q2 FY26

    Approximately 53% of unsecured notes due in 2027, part of Step 1 of the refinancing.

    Longer-dated unsecured notes exchanged
    $1.2 billion
    Q2 FY26

    Exchanged at a discount as part of Step 1 of the refinancing.

    Gross debt reduction from exchange
    $123 million
    Q2 FY26

    Resulting from the exchange of longer-dated unsecured notes.

    Term loan due June 2027 repaid
    $200 million
    Q2 FY26

    To be repaid as part of Step 2 of the refinancing.

    Sole maturity over next 3 years
    $600 million
    June 2028

    After completion of refinancing steps.

    Expected liquidity
    $1.1 billion
    near-term

    Based on recent and expected near-term asset sales.

    UA UD bond covenant minimum
    1.5x
    ongoing

    Minimum requirement for the unencumbered assets over unsecured debt covenant.

    UA UD bond covenant prior
    1.55x to 1.60x
    prior quarters

    Range over the last several quarters.

    UA UD bond covenant after Step 1
    almost 200%up from 155-160%
    Q2 FY26

    Expected after completion of Step 1 of the refinancing.

    UA UD bond covenant after Step 2
    up to 300%
    Q2 FY26

    Expected after completion of Step 2 of the refinancing.

    New secured notes coupon
    9.25%
    ongoing

    Coupon for the new secured notes issued as part of Step 1.

    New secured notes term
    5.5 years
    ongoing

    Term for the new secured notes.

    Infracore IPO proceeds
    $140 million
    Q2 FY26

    Proceeds generated for MPT from the Infracore IPO.

    Pending asset sale proceeds
    $172 million
    Q2 FY26

    From a transaction closing imminently, reflecting a 60% increase over original investment and a 34% IRR.

    Additional asset sales expected
    $200 million to $400 million
    next few weeks

    Expected cash proceeds from a handful of other significantly valued assets.

    HSA EBITDARM to cash rent coverage
    2x
    trailing 12-month

    Trailing 12-month coverage for HSA.

    HSA contractual rent payment
    75%
    current

    Current contractual rent payment percentage for HSA.

    NOR contractual rent payment
    50%
    started mid-June

    Contractual rent payment percentage for NOR.

    HSA cash collections
    82%up from 78%
    last quarter

    Previously indicated cash collection rate for HSA.

    HSA cash collections
    78%
    prior to last quarter

    Previous cash collection rate for HSA.

    Current revolver capacity
    $1.3 billion
    Q2 FY26

    Current revolver capacity, assuming a meaningful decline.

    Norwood cost basis
    $350 million
    Q2 FY26

    As stated in some filings, analyst impression was $200 million.

    Post-acute EBITDARM increase
    $70 million
    YoY

    Strongest growth in the portfolio for post-acute operators.

    Secured debt ratio prior
    25%
    prior to Step 1

    Secured debt ratio before the Step 1 issuance.

    Secured debt ratio after Step 1
    closer to 40%
    Q2 FY26

    Secured debt ratio after the Step 1 issuance, approaching the 40% covenant.

    Industry KPIs

    3
    MetricValueDetails
    Coverage ratios2.8xx
    Operator tenant concentrationConsolidated
    Investment volume and sourcing mix$140 millionUSD

    Deals & partnerships

    3
    InfracoreSwiss joint venture went public and listed on SIX Exchange.

    MPT retains a significant ownership position and remains bullish on Switzerland.

    LifePoint / ScionHealthConsolidated all ScionHealth general acute hospitals and LifePoint leases into one LifePoint master lease.

    Scion transitioned certain MPT-owned acute hospitals to LifePoint.

    Ernest HealthErnest Health's acquisition of Reunion Rehabilitation Hospital.

    MPT is excited to see Ernest continue to grow with this acquisition.

    Capital programs

    1
    Culver City Emergency Department projectprogressing

    The emergency department project at Culver City is progressing and remains scheduled to open in the fourth quarter of 2027.

    Risks & headwinds

    4
    Behavioral Health segment pressureQ2 FY26

    EBITDARM coverage down slightly to 1.4x.

    Mitigation: Management impressed with activity, confident in opportunities, encouraged by long-term investment potential.

    U.K. NHS funding pressuresOngoing

    Revenue impacted.

    Mitigation: Priory taking proactive measures, implementing disciplined cost control, optimizing services.

    HSA operational disruptions (EMR conversion, RCM transition, delayed Florida funding)Q2 FY26

    Lower cash collections and volume declines in some markets; cash collections still lagging.

    Mitigation: MEDITECH conversion largely behind them; RCM brought back in-house; expects to improve revenue cycle and operational efficiency; received significant Florida payments in August.

    Impairment of working capital loansQ2 FY26

    $17 million impaired.

    Mitigation: Primarily related to Steward replacement tenants in the Midwest.

    What to watch in Q3 FY26

    5

    HSA cash collections improvement

    Next quarter
    CurrentStill lagging (previously 82%, dipped from 78%)
    TargetImproved cash collections, approaching 90%+ range.

    Why it matters

    Critical for HSA's liquidity and MPT's rent collection, impacting FFO.

    While cash collections are still lagging, HSA has received significant payments from the Florida supplemental funding program in August, enabling them to begin repayment of the working capital advances we made during the quarter. While trailing 12-month EBITDARM to cash rent coverage of 2x, we remain cautiously optimistic💬 about the trajectory of HSA and we'll continue carefully monitoring their operations.

    Q&A highlights

    5

    Inquired if the balance of 2027 notes would be paid off using a new credit line and the associated rate.

    Steve Hamner clarified that the repayment of 2027 notes (Step 2) would not solely rely on a credit line, but rather a combination of asset sales, existing liquidity, and additional secured debt opportunities.

    “No. We have a number of options that we've always had including asset sales, including liquidity that we have and including additional secured debt opportunities.”

    asked by Mike Mueller · answered by R. Hamner

    2 min read5 chapters

    Detailed Narrative

    01

    Debt Refinancing Strategy

    MPT announced a two-step refinancing process to address $2.7 billion in 2026 and 2027 debt maturities, plus an additional $1.2 billion of longer-dated unsecured notes. Step 1 involves issuing $2.4 billion in secured notes to redeem EUR 500 million of 2026 notes and approximately $738 million (53%) of 2027 notes, while exchanging $1.2 billion of longer-dated notes at a discount, reducing gross debt by $123 million. Step 2 will repay the remainder of the 2027 notes, establish a new multiyear bank revolver, and repay a $200 million term loan due June 2027, resulting in no debt maturities until June 2028.

    02

    Asset Valuation and Sales

    The company highlighted that market values of its hospital assets exceed book values, affirmed by the Infracore IPO and recent transactions. A pending sale is expected to generate $172 million in after-debt cash proceeds, reflecting a 60% increase over original investment and a 34% IRR. MPT is negotiating additional asset sales that could generate $200 million to $400 million more in cash proceeds, also at significant gains over original investments.

    03

    Operator Performance and Challenges

    Post-acute operators, including Median (24% increase) and Ernest Health (13% increase), showed strong EBITDARM growth, contributing to a 2.4x coverage. General acute operators maintained 2.8x coverage. However, Behavioral Health coverage declined to 1.4x due to U.K. funding pressures and U.S. market headwinds🌐. HSA faced disruptions from an EMR conversion and delayed Florida supplemental funding, impacting cash collections, though operational coverage was 2x.

    04

    Lease Consolidation and Rent Escalations

    MPT consolidated all ScionHealth general acute hospitals and LifePoint leases into a single LifePoint master lease, maintaining cash rent levels. NOR began paying 50% contractual rent in June, increasing to 100% in mid-December, while HSA is currently paying 75% contractual rent, increasing to 100% in mid-September.

    05

    Liquidity and Leverage

    Upon completion of the refinancings and asset sales, MPT expects to have up to $1.1 billion in liquidity. The UA UD bond covenant cushion is projected to improve significantly, from 155-160% to almost 200% after Step 1, and potentially up to 300% after Step 2, providing substantial flexibility for further deleveraging.

    AI-generated summary of the company’s earnings call. Not investment advice.